Allogeneic bone marrow transplant, also known as allogeneic stem cell transplant, is a procedure in which a bone marrow that is not producing enough healthy blood cells is replaced with healthy blood stem cells from a donor.
An allogeneic bone marrow transplant may be performed in the following cases:
Acute or chronic leukemia (a type of blood cancer)
Aplastic anemia (when the body stops producing enough new blood cells due to bone marrow damage)
Adrenoleukodystrophy (a hereditary condition that leads to the damage to the membrane that insulates the nerve cells in the brain)
Bone marrow failure syndromes (a group of genetic blood disorders)
Hodgkin’s or Non-Hodgkin’s lymphoma (cancer that starts in the lymphatic system)
Hemoglobinopathies (an inherited condition in which there is an abnormal structure or production of the hemoglobin molecule)
Immune deficiencies (when the body’s immune or disease-fighting system fails to work properly)
Metabolic disorders (when several conditions occur together increasing the risk of diabetes, stroke, and diabetes)
Multiple myeloma (cancer of the plasma cells, which are a type of white blood cells in the bone marrow)
Myelodysplastic syndromes (a group of disorders that disrupts blood cell production)
Neuroblastoma (a type of cancer commonly found in the adrenal glands, which are located on top of the kidneys)
Plasma cell disorders (a type of blood cancer)
Primary amyloidosis (a rare disease that occurs when the abnormal light chain proteins in the body gather on the tissues and organs)
POEMS syndrome (a rare blood disorder that damages the nerves and affects other body parts)
The following diagnostic tests may be performed before an allogeneic bone marrow transplant:
The side effects of allogeneic bone marrow transplant include the following: